The US FDA has approved Ionis-AstraZeneca to treat rare nerve diseases. The US Food and Drug Administration approved Ionis Pharmaceuticals and partner AstraZeneca's drug to treat rare nerve diseases on Thursday.
US FDA Approves Ionis-AstraZeneca To Treat Rare Nerve Disease hngn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hngn.com Daily Mail and Mail on Sunday newspapers.
The investigational antisense agent eplontersen slows disease progression and im-proves quality of life in hereditary transthyretin-mediated amyloid polyneuropathy, final data from a phase 3 trial indicate.
After a harrowing journey fleeing the ongoing war in Ukraine, a father who was recently deported from Canada is pleading with Prime Minister Trudeau for help as he and his family make their way to Germany.
A father who was recently deported from Canada is appealing to the federal government for help after he and his family made the harrowing journey out of Ukraine.